Cargando…
A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy
Iron deficiency anemia (IDA) is the most common form of anemia worldwide. Although oral iron is used as first-line treatment, many patients are unresponsive to or cannot take oral iron. This Phase III, open-label, non-inferiority study compared the efficacy and safety of ferumoxytol, a rapid, inject...
Autores principales: | Hetzel, David, Strauss, William, Bernard, Kristine, Li, Zhu, Urboniene, Audrone, Allen, Lee F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225478/ https://www.ncbi.nlm.nih.gov/pubmed/24639149 http://dx.doi.org/10.1002/ajh.23712 |
Ejemplares similares
-
Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open-label, 6-month extension study
por: Vadhan-Raj, Saroj, et al.
Publicado: (2016) -
Ferumoxytol for the treatment of iron deficiency and iron-deficiency
anemia of pregnancy
por: Gerb, Jesse, et al.
Publicado: (2021) -
Efficacy and safety of IV ferumoxytol for iron deficiency anemia in patients with cancer
por: Vadhan-Raj, Saroj, et al.
Publicado: (2017) -
Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia
previously unresponsive to or unable to tolerate oral iron
por: Vadhan-Raj, Saroj, et al.
Publicado: (2014) -
Ferumoxytol versus placebo in iron deficiency anemia: efficacy, safety, and quality of life in patients with gastrointestinal disorders
por: Ford, David C, et al.
Publicado: (2016)